Postual Control in Pediatric Chiari I Malformation
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Dec 17, 2020
Trial Information
Current as of June 01, 2025
Unknown status
Keywords
ClinConnect Summary
Chiari malformation is characterized by at least 5 mm descent of cerebellar tonsils below the foramen magnum, into the vertebral canal. Historical classification of this malformation consists in four different types, but it is the first one, due to a congenital small posterior fossa, which represent our focus of interest. Chiari malformation may leads to direct brainstem compression and to cerebrospinal fluid circulation trouble at this level, being cause of classical associated phenomena such as syringomyelia formation.
The clinical manifestation may be resumed as follow:
* Exertional he...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Radiologically confirmed diagnosis of Chiari I malformation (first MRI realized up to 1/01/2018)
- • ENT symptomes (dizziness, nystagmus, gait imbalance, migraines not due to the presence of Chiari Malformation)
- Exclusion Criteria:
- • Lack of cooperation (cerebral palsy, severe behavioral troubles, orthopedic illness, severe visual impairment)
- • Patient's consent for study non obtained.
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vandœuvre Lès Nancy, Lorraine, France
Patients applied
Trial Officials
Perrin Philippe, PhD
Study Director
Nancy Regional University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials